[go: up one dir, main page]

DE60021373D1 - Verfahren der zellkultivierung - Google Patents

Verfahren der zellkultivierung

Info

Publication number
DE60021373D1
DE60021373D1 DE60021373T DE60021373T DE60021373D1 DE 60021373 D1 DE60021373 D1 DE 60021373D1 DE 60021373 T DE60021373 T DE 60021373T DE 60021373 T DE60021373 T DE 60021373T DE 60021373 D1 DE60021373 D1 DE 60021373D1
Authority
DE
Germany
Prior art keywords
cell cultivation
cell
culturing
protein
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60021373T
Other languages
English (en)
Other versions
DE60021373T2 (de
Inventor
Yasuko Ozaki
Yasuo Koishihara
Shin-Ichi Kaiho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE60021373D1 publication Critical patent/DE60021373D1/de
Application granted granted Critical
Publication of DE60021373T2 publication Critical patent/DE60021373T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60021373T 1999-05-10 2000-05-10 Verfahren der zellkultivierung Expired - Lifetime DE60021373T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12861499 1999-05-10
JP12861499 1999-05-10
PCT/JP2000/002997 WO2000068371A1 (fr) 1999-05-10 2000-05-10 Procede de culture cellulaire

Publications (2)

Publication Number Publication Date
DE60021373D1 true DE60021373D1 (de) 2005-08-25
DE60021373T2 DE60021373T2 (de) 2006-04-27

Family

ID=14989150

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60021373T Expired - Lifetime DE60021373T2 (de) 1999-05-10 2000-05-10 Verfahren der zellkultivierung

Country Status (13)

Country Link
US (1) US6900052B1 (de)
EP (1) EP1176194B1 (de)
JP (1) JP4721522B2 (de)
KR (1) KR20020013538A (de)
CN (1) CN1182244C (de)
AT (1) ATE299932T1 (de)
AU (1) AU778787B2 (de)
CA (1) CA2372585A1 (de)
DE (1) DE60021373T2 (de)
ES (1) ES2241599T3 (de)
HK (2) HK1045715B (de)
NO (1) NO20015494L (de)
WO (1) WO2000068371A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669109B2 (en) 2003-08-19 2014-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of producing proteins in Chinese hamster ovary (CHO) cells
PL1694828T3 (pl) * 2003-12-19 2011-11-30 Wyeth Llc Sposób wytwarzania wolnych od surowicy banków komórek Vero
AU2008284015B2 (en) 2007-08-03 2014-05-15 Musc Foundation For Research Development Human monoclonal antibodies and methods for producing the same
EP2417248B1 (de) 2009-04-09 2019-05-22 Sartorius Stedim Cellca GmbH Verfahren zur verbesserten Einzelzellklonung
KR101961580B1 (ko) 2015-01-26 2019-03-22 우베 고산 가부시키가이샤 물질의 생산 방법
TWI851703B (zh) * 2019-04-02 2024-08-11 日商中外製藥股份有限公司 標的特異性外源基因的導入方法
CN112980909A (zh) * 2021-02-26 2021-06-18 通用生物系统（安徽）有限公司 一种杂交瘤细胞无血清培养制备抗体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8911356D0 (en) 1989-05-17 1989-07-05 Torrance Lesley A composition and a process to increase the survival of hybridoma cells
JPH0346562A (ja) * 1989-07-14 1991-02-27 Matsushita Electric Ind Co Ltd 免疫方法および免疫測定方法
WO1991003553A1 (en) * 1989-09-05 1991-03-21 Immunex Corporation TUMOR NECROSIS FACTOR-α AND -β RECEPTORS
NL9101680A (nl) 1991-10-04 1993-05-03 Tno Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
KR100847441B1 (ko) * 1996-09-26 2008-07-21 츄가이 세이야꾸 가부시키가이샤 인간의 부갑상선 호르몬 관련 펩티드에 대한 항체
UA76934C2 (en) 1996-10-04 2006-10-16 Chugai Pharmaceutical Co Ltd Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
JP3587664B2 (ja) * 1996-10-04 2004-11-10 中外製薬株式会社 再構成ヒト抗ｈｍ１．２４抗体
DE19653358A1 (de) 1996-12-20 1998-06-25 Boehringer Mannheim Gmbh Immunoassay zum Nachweis von MIA

Also Published As

Publication number Publication date
CN1350580A (zh) 2002-05-22
WO2000068371A1 (fr) 2000-11-16
WO2000068371A8 (fr) 2001-04-26
KR20020013538A (ko) 2002-02-20
AU4430500A (en) 2000-11-21
HK1045715A1 (en) 2002-12-06
EP1176194A4 (de) 2002-09-18
EP1176194B1 (de) 2005-07-20
HK1045715B (zh) 2005-06-03
CN1182244C (zh) 2004-12-29
US6900052B1 (en) 2005-05-31
CA2372585A1 (en) 2000-11-16
HK1042522A1 (en) 2002-08-16
DE60021373T2 (de) 2006-04-27
NO20015494L (no) 2002-01-09
ES2241599T3 (es) 2005-11-01
NO20015494D0 (no) 2001-11-09
ATE299932T1 (de) 2005-08-15
JP4721522B2 (ja) 2011-07-13
EP1176194A1 (de) 2002-01-30
AU778787B2 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
CY1108329T1 (el) Κυτταρικη καλλιεργεια
DE59906513D1 (de) Verfahren zur vernetzung von hydrogelen mit bis- und poly-2-oxazolidinonen
BR9803807B1 (pt) processo para preparação de uma enzima heteróloga através do cultivo de uma célula eucariótica transformada.
DK0843961T3 (da) Kimærisk mus og fremgangsmåde til at producere samme
FI923874A0 (fi) Medel foer bildande av hepatocytsferoider och foerfarande foer bildande av sferoider genom odling av hepatocyter.
ATE153214T1 (de) Medien zur zellzucht und verfahren dazu
DE60043640D1 (de) Kontinuierliche Fermentation
DK1085083T3 (da) Dyrkningsmedium for dyreceller og fremgangsmåde til proteinfremstilling under anvendelse af dette
ATE536372T1 (de) Verfahren zur hoher expression der aktiven form von lymphotoxin-beta-rezeptor-immunglobulin fusionsproteinen, und deren reinigung
ATE553210T1 (de) Verfahren zur herstellung von l-threonin unter verwendung eines mikroorganismus mit inaktivierten galr gen.
DK1495112T3 (da) Cellekulturmedium
DE60329640D1 (de) Verfahren zur Herstellung von N-Monoalkyl-Beta-Aminoalkoholen
ATE299932T1 (de) Verfahren der zellkultivierung
AU2001269445A1 (en) Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same
FI922409L (fi) Foerfarande foer cellodling.
DE69832662D1 (de) Verfahren zur Kultur von Hepatocyten
DE60129547D1 (de) Verfahren zur kultivierung von mikroorganismen
ATE166392T1 (de) Verfahren zur modulierung der produktion von sekundären metaboliten
DK0756003T3 (da) Fremgangsmåde til dyrkning af dyreceller
CY1109583T1 (el) Κυτοκινες θηλαστικων, αντιστοιχα αντιδραστηρια
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DE10158713A8 (de) Träger mit immobilisierten Antigenen oder Antikörpern und Verfahren zu dessen Herstellen
DE60126865D1 (de) Enzymatisches Verfahren zur Markierung von Proteinen mit Isotopen
DE60236303D1 (de) Verfahren zur herstellung von 14-beta-hydroxybaccatin-iii-1,14-carbonat
ATE306521T1 (de) Polycarbonat-substrate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition